secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hyperliquid Strategies Inc (PURR)
CIK:        0002078856
Form:       8-K
Filed at:   2025-12-03T23:59:59+00:00
Accession:  0001493152-25-025886
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 1.01, 3.02, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hyperliquid Strategies completes business combination; trades as PURR on Nasdaq Dec 3
--------------------------------------------------------------------------------

- Closed acquisition of Sonnet BioTherapeutics and Rorschach I LLC; combined entity has ~127M shares outstanding.
- New board of eight directors including Bob Diamond, Eric Rosengren, Thomas King; David Schamis remains CEO.
- Issued to advisor warrants for up to 27.4M shares at exercise prices $9.375, $12.50, and $18.75.
- Stock begins trading on Nasdaq Capital Market under ticker PURR on December 3, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2078856/000149315225025886/0001493152-25-025886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2078856/000149315225025886/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer